封面
市場調查報告書
商品編碼
1455276

2024 年醫療設備報銷全球市場報告

Medical Devices Reimbursement Global Market Report 2024

出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年醫療設備報銷市場規模將大幅成長。預計到 2028 年將以 8.9% 的複合年成長率 (CAGR) 成長至 8,466.2 億美元。預測期內的預期成長是由基於價值的醫療保健模式的採用、對精準醫療的需求不斷增加、解決全球醫療保健安全問題、日益重視以患者為中心的護理以及與醫療技術評估的合作推動的。各種因素,包括環境措施。 (HTA),以及政府對醫療保健的重大投資。預測期內預期的顯著趨勢包括數位醫療技術的整合、製造商和付款人之間的合作協議、對現實世界證據和健康經濟資料的關注、採用按績效付費模型和價值評估。包括框架實施, ETC。 ,風險共用的進展。

在可預見的未來,微創手術需求的增加預計將成為醫療設備報銷市場成長的主要驅動力。與傳統的開放性手術相比,微創手術 (MIS) 需要專門的技術和儀器,以便在對患者身體造成最小損傷的情況下進行手術。微創手術醫療設備報銷的好處包括透過提高患者接受先進手術的機會和縮短住院時間來節省成本。根據英國醫療組織 Private Clinic Group Limited 的報告,2021 年,全球整形外科醫師進行了超過 1,280 萬例外科手術和超過 1,750 萬例非手術治療。與去年相比,整形外科醫生進行的手術數量大幅增加了 19.3%。因此,微創手術需求的不斷成長是推動醫療設備報銷市場成長的關鍵因素。

慢性病盛行率的不斷上升預計將進一步推動醫療設備報銷市場的擴大。慢性病的特徵是長期性,通常是可以控制但無法治癒的疾病,我們的目標是在確保可近性、促進創新和改善患者治療效果的同時減輕經濟負擔,需要有效的醫療設備報銷。據美國醫學圖書館National Library of Medicine稱,到2050年,預計99.5%的人口將患有慢性病,從2020年的71,522,000人增加到142,660,000人。同時,患有複雜疾病的人數預計將從2020年的783.04萬人增加到2050年的1496.8萬人,大幅增加91.16%。因此,慢性病盛行率的上升正在推動醫療設備報銷市場的持續成長。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球醫療設備報銷市場的促進因素與阻礙因素
    • 市場驅動力
    • 市場限制
  • 2018-2023年全球醫療設備報銷市場規模表現及成長率
  • 2023-2028、2033年全球醫療設備報銷市場規模及成長預測

第6章市場區隔

  • 全球醫療設備報銷市場,依保險公司細分,績效與預測,2018-2023、2023-2028、2033
  • 民眾
  • 私人的
  • 全球醫療設備報銷市場,按申請細分、實際和預測,2018-2023、2023-2028、2033
  • 小數量
  • 全額
  • 全球醫療設備報銷市場,按醫療保健環境、績效和預測細分,2018-2023、2023-2028、2033
  • 醫院
  • 門診設施
  • 其他醫療保健環境

第 7 章 區域與國家分析

  • 全球醫療設備報銷市場,按地區、實際和預測,2018-2023、2023-2028、2033
  • 全球醫療設備報銷市場,按國家/地區、績效和預測,2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 醫療設備報銷市場競爭格局
  • 醫療設備報銷市場公司概況
    • UnitedHealth Group
    • CVS Health Corporation
    • Cigna Corporation
    • Anthem Insurance Companies Inc.
    • Axa SA

第31章 其他重大及創新企業

  • Assicurazioni Generali SpA
  • Humana Inc.
  • Reliance Nippon Life Insurance Company Limited
  • MetLife Services and Solutions LLC
  • Aetna Inc.
  • New York Life Insurance
  • Nationwide Mutual Insurance Company
  • American International Group Inc.
  • Allstate Insurance Company
  • BNP Paribas SA
  • Zurich Insurance Group Ltd.
  • Aegon Life Insurance Company
  • Aviva plc
  • WellCare Health Plans Inc.
  • Pacific Life Insurance Company

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章 未來前景與可能性分析

第36章附錄

簡介目錄
Product Code: r16277

Medical device reimbursement is the procedure through which healthcare providers receive payment from insurance plans or payers for supplying patients with medically necessary devices. This entails assessing the device's cost, evaluating its efficacy, and engaging in negotiations with payers to secure insurance coverage.

The primary contributors to medical device reimbursement are public and private entities. Public payers refer to government-funded organizations or entities tasked with financing and overseeing healthcare services for a designated population or country. Hospitals, outpatient facilities, and various healthcare settings submit claims for both underpaid and fully reimbursed services.

The medical device reimbursement market research report is one of a series of new reports from The Business Research Company that provides medical device reimbursement market statistics, including medical device reimbursement industry global market size, regional shares, competitors with a medical device reimbursement market share, detailed medical device reimbursement market segments, market trends and opportunities, and any further data you may need to thrive in the medical device reimbursement industry. This medical device reimbursement market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The medical devices reimbursement market size has grown strongly in recent years. It will grow from $549.53 billion in 2023 to $602.26 billion in 2024 at a compound annual growth rate (CAGR) of 9.6%. The expansion observed in the historical period can be ascribed to several factors, including government healthcare policies, a rising burden of diseases, enhanced patient access and affordability, efforts to contain healthcare costs, collaborative initiatives between providers and payers, and an escalating focus on regulatory compliance.

The medical devices reimbursement market size is expected to see strong growth in the next few years. It will grow to $846.62 billion in 2028 at a compound annual growth rate (CAGR) of 8.9%. The anticipated growth in the forecast period is linked to various factors, such as the adoption of value-based healthcare models, increasing demand for precision medicine, global health security initiatives, a heightened emphasis on patient-centric care, collaborative efforts with health technology assessment (HTA), and substantial government investments in healthcare. Noteworthy trends expected in the forecast period encompass the integration of digital health technologies, collaborative agreements between manufacturers and payers, a focus on real-world evidence and health economics data, the adoption of pay-for-performance models, the implementation of value assessment frameworks, and advancements in risk-sharing agreements.

The increasing demand for minimally invasive surgeries is anticipated to be a key driver for the growth of the medical device reimbursement market in the foreseeable future. Minimally Invasive Surgery (MIS) involves specialized techniques and instruments that enable surgical procedures with minimal disruption to the patient's body, in contrast to traditional open surgery. The advantages of medical device reimbursement in the context of minimally invasive surgery include enhanced patient access to advanced procedures and cost savings due to shorter hospital stays. As reported by Private Clinic Group Limited, a UK-based medical organization, in 2021, plastic surgeons globally performed over 12.8 million surgical procedures and 17.5 million non-surgical treatments. This marked a substantial 19.3% increase in procedures performed by plastic surgeons compared to the previous year. Consequently, the rising demand for minimally invasive surgeries is a significant factor propelling the growth of the medical device reimbursement market.

The increasing prevalence of chronic diseases is expected to further drive the expansion of the medical device reimbursement market. Chronic diseases, characterized by their long-term nature and typically manageable but incurable status, necessitate effective medical device reimbursement for accessibility, fostering innovation, and improving patient outcomes while mitigating economic burdens. According to the National Library of Medicine, a US-based medical library, an estimated 99.5% of the population is projected to have a chronic illness by 2050, increasing from 71.522 million in 2020 to 142.66 million. Concurrently, the number of individuals with multimorbidity is anticipated to rise from 7.8304 million in 2020 to 14.968 million in 2050, reflecting a substantial 91.16% increase. Therefore, the growing prevalence of chronic diseases stands as a driving force behind the sustained growth of the medical device reimbursement market.

The high cost of medical devices, coupled with insufficient claims reimbursement, poses a potential hindrance to the growth of the medical device reimbursement market during the forecast period. The adoption of innovative medical devices in hospitals faces challenges due to these elevated costs. For instance, as reported by AdvaMed, a US-based medical technology association representing device, diagnostics, and digital technology companies, the average annual increase in medical device prices in June 2021 is a mere 0.4%, contrasting sharply with the 2.4% rise in the Consumer Price Index (CPI). Consequently, the substantial costs associated with medical devices are impeding the expansion of the medical device reimbursement market.

Major players in the medical device reimbursement market are strategically focusing on technological advancements, exemplified by the development of electronic medical records (EMRs), to maintain their market positions. Electronic medical records serve as digital versions of a patient's paper medical charts and play a crucial role in supporting reimbursement claims by ensuring the medical necessity and appropriate utilization of devices. For instance, in April 2023, Wemex Corporation, a Japan-based IT solutions company, introduced the medicom-HRf hybrid cloud, an integrated EMR system utilizing cloud technology to facilitate location-free operations for clinics. Hybrid cloud solutions such as Medicom-HRf seamlessly integrate various data sources, including patient records, medical billing, insurance claims, and regulatory information. This integration offers a comprehensive view of a patient's treatment and billing history, crucial for accurate reimbursement. Medical device companies can leverage such systems to access up-to-date information on insurance coverage, reimbursement rates, and claim status.

In January 2022, Centene Corporation, a US-based managed care company, completed the acquisition of Magellan Health Inc. for an undisclosed amount. This strategic move enables Centene Corporation to deliver innovative and integrated healthcare solutions, resulting in improved health outcomes at lower costs, particularly for complex and high-cost health treatments. Magellan Health Inc., as a managed care company, brings expertise in offering solutions for health plans and reimbursement management, covering a spectrum of devices and healthcare services within the healthcare landscape.

Major companies operating in the medical devices reimbursement market report are UnitedHealth Group, CVS Health Corporation, Cigna Corporation, Anthem Insurance Companies Inc., Axa S.A., Assicurazioni Generali SpA, Humana Inc., Reliance Nippon Life Insurance Company Limited, MetLife Services and Solutions LLC, Aetna Inc., New York Life Insurance, Nationwide Mutual Insurance Company, American International Group Inc., Allstate Insurance Company, BNP Paribas S.A., Zurich Insurance Group Ltd., Aegon Life Insurance Company, Aviva PLC, WellCare Health Plans Inc., Pacific Life Insurance Company, Allianz SE, Bright House Financial Inc., Globe Life Inc., Munich Re Group, Symetra Life Insurance Company, Sumitomo Life Insurance Company, NAMSA Inc., Colonial Penn Life Insurance Company, Musculoskeletal Clinical Regulatory Advisers LLC, Assurity Life Insurance

North America was the largest region in the medical devices reimbursement market in 2023. The regions covered in the medical devices reimbursement market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the medical devices reimbursement market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical devices reimbursement market includes revenues earned by entities by providing services such as coding and billing services, claims processing, coverage determination, benefit verification, coding and billing training, and pre-authorization and pre-certification. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Medical Devices Reimbursement Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on medical devices reimbursement market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for medical devices reimbursement ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The medical devices reimbursement market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Payer: Public; Private
  • 2) By Claims: Underpaid; Full
  • 3) By Healthcare Setting: Hospitals; Outpatient Facilities; Other Healthcare Settings
  • Companies Mentioned: UnitedHealth Group; CVS Health Corporation; Cigna Corporation; Anthem Insurance Companies Inc.; Axa S.A.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Medical Devices Reimbursement Market Characteristics

3. Medical Devices Reimbursement Market Trends And Strategies

4. Medical Devices Reimbursement Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Medical Devices Reimbursement Market Size and Growth

  • 5.1. Global Medical Devices Reimbursement Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Medical Devices Reimbursement Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Medical Devices Reimbursement Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Medical Devices Reimbursement Market Segmentation

  • 6.1. Global Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Public
  • Private
  • 6.2. Global Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Underpaid
  • Full
  • 6.3. Global Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Outpatient Facilities
  • Other Healthcare Settings

7. Medical Devices Reimbursement Market Regional And Country Analysis

  • 7.1. Global Medical Devices Reimbursement Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Medical Devices Reimbursement Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Medical Devices Reimbursement Market

  • 8.1. Asia-Pacific Medical Devices Reimbursement Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Medical Devices Reimbursement Market

  • 9.1. China Medical Devices Reimbursement Market Overview
  • 9.2. China Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Medical Devices Reimbursement Market

  • 10.1. India Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Medical Devices Reimbursement Market

  • 11.1. Japan Medical Devices Reimbursement Market Overview
  • 11.2. Japan Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Medical Devices Reimbursement Market

  • 12.1. Australia Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Medical Devices Reimbursement Market

  • 13.1. Indonesia Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Medical Devices Reimbursement Market

  • 14.1. South Korea Medical Devices Reimbursement Market Overview
  • 14.2. South Korea Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Medical Devices Reimbursement Market

  • 15.1. Western Europe Medical Devices Reimbursement Market Overview
  • 15.2. Western Europe Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Medical Devices Reimbursement Market

  • 16.1. UK Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Medical Devices Reimbursement Market

  • 17.1. Germany Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Medical Devices Reimbursement Market

  • 18.1. France Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Medical Devices Reimbursement Market

  • 19.1. Italy Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Medical Devices Reimbursement Market

  • 20.1. Spain Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Medical Devices Reimbursement Market

  • 21.1. Eastern Europe Medical Devices Reimbursement Market Overview
  • 21.2. Eastern Europe Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Medical Devices Reimbursement Market

  • 22.1. Russia Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Medical Devices Reimbursement Market

  • 23.1. North America Medical Devices Reimbursement Market Overview
  • 23.2. North America Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Medical Devices Reimbursement Market

  • 24.1. USA Medical Devices Reimbursement Market Overview
  • 24.2. USA Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Medical Devices Reimbursement Market

  • 25.1. Canada Medical Devices Reimbursement Market Overview
  • 25.2. Canada Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Medical Devices Reimbursement Market

  • 26.1. South America Medical Devices Reimbursement Market Overview
  • 26.2. South America Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Medical Devices Reimbursement Market

  • 27.1. Brazil Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Medical Devices Reimbursement Market

  • 28.1. Middle East Medical Devices Reimbursement Market Overview
  • 28.2. Middle East Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Medical Devices Reimbursement Market

  • 29.1. Africa Medical Devices Reimbursement Market Overview
  • 29.2. Africa Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Medical Devices Reimbursement Market Competitive Landscape And Company Profiles

  • 30.1. Medical Devices Reimbursement Market Competitive Landscape
  • 30.2. Medical Devices Reimbursement Market Company Profiles
    • 30.2.1. UnitedHealth Group
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. CVS Health Corporation
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Cigna Corporation
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Anthem Insurance Companies Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Axa S.A.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Medical Devices Reimbursement Market Other Major And Innovative Companies

  • 31.1. Assicurazioni Generali SpA
  • 31.2. Humana Inc.
  • 31.3. Reliance Nippon Life Insurance Company Limited
  • 31.4. MetLife Services and Solutions LLC
  • 31.5. Aetna Inc.
  • 31.6. New York Life Insurance
  • 31.7. Nationwide Mutual Insurance Company
  • 31.8. American International Group Inc.
  • 31.9. Allstate Insurance Company
  • 31.10. BNP Paribas S.A.
  • 31.11. Zurich Insurance Group Ltd.
  • 31.12. Aegon Life Insurance Company
  • 31.13. Aviva plc
  • 31.14. WellCare Health Plans Inc.
  • 31.15. Pacific Life Insurance Company

32. Global Medical Devices Reimbursement Market Competitive Benchmarking

33. Global Medical Devices Reimbursement Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Medical Devices Reimbursement Market

35. Medical Devices Reimbursement Market Future Outlook and Potential Analysis

  • 35.1 Medical Devices Reimbursement Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Medical Devices Reimbursement Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Medical Devices Reimbursement Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer